NPPA fixes price of Cipla Synchrobreathe inhaler device; Details Medical Dialogues Bureau22 Dec 2019 8:56 AM GMTNew Delhi: Price of Synchrobreathe inhaler device manufactured by pharma giant Cipla has been set at Rs 67.20 after the National Pharmaceutical...
Cipla moves against NPPA for price fixation of asthma drugs; DOP junks plea Farhat Nasim16 Jun 2019 6:14 AM GMTNew Delhi: Mumbai-based drugmaker, Cipla Limited's review petition against the Government regulatory agency, National Pharmaceutical Pricing Authority...